When we think partnerships, we think diverse, bold, and inspired. It's in those partnerships where we can find an innovative medicine that saves a life. Or the licensing deal that broadens access to a critical drug. Or the technology collaboration that brings an experimental medicine to clinical trials faster. Or, even a business process that improves the way we help our customers.
Our partnerships, while individualized in scope and breadth, all offer the possibility of a healthier world. Read about some of our partnerships
|October 3, 2011||MEDIMMUNE IN-LICENSES CANCER IMMUNOTHERAPY|
|September 29, 2011||Lpath Initiates Dosing of iSONEP|
|September 28, 2011||International Structural Genomics Consortium Announces $48.9 MILLION in Additional Funding|
|August 29, 2011||Jennewein Biotechnologie and Pfizer Nutrition Collaborate|
|August 16, 2011||QIAGEN and Pfizer partner to develop companion diagnostic|
|August 3, 2011||Biotica regains worldwide rights to its rapamycin analogue program|